Ticker > Company >

Granules India share price

Granules India Ltd.

NSE: GRANULES BSE: 532482 SECTOR: Pharmaceuticals & Drugs  2.16 L   1.2 K   251

490.30
+27.35 (5.91%)
BSE: 29 Jul 04:01 PM

Price Summary

Today's High

₹ 491.45

Today's Low

₹ 462.95

52 Week High

₹ 724.55

52 Week Low

₹ 412.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

11896.82 Cr.

Enterprise Value

12534.68 Cr.

No. of Shares

24.26 Cr.

P/E

37.25

P/B

3.51

Face Value

₹ 1

Div. Yield

0.31 %

Book Value (TTM)

₹  139.68

CASH

170.34 Cr.

DEBT

808.19 Cr.

Promoter Holding

38.82 %

EPS (TTM)

₹  13.16

Sales Growth

-19.31%

ROE

9.85 %

ROCE

11.7%

Profit Growth

-26.74 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Granules India Ltd.

Dolo Metrogyl Aciloc Udiliv Sporlac Shelcal paracetamol

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-19.31%
3 Year-2.19%
5 Year5.58%

Profit Growth

1 Year-26.74%
3 Year-6.17%
5 Year-6.38%

ROE%

1 Year9.85%
3 Year14.7%
5 Year17.72%

ROCE %

1 Year11.7%
3 Year16.1%
5 Year18.23%

Debt/Equity

0.2385

Price to Cash Flow

14.46

Interest Cover Ratio

7.8051

CFO/PAT (5 Yr. Avg.)

1.12078634844304

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 38.82 0.00
Mar 2025 38.84 0.00
Dec 2024 38.85 0.00
Sep 2024 38.87 0.00
Jun 2024 38.87 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The Company has been maintaining an effective average operating margins of 21.5700343374845% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 75.6009 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.12078634844304.

 Limitations

  • The company has shown a poor profit growth of -6.16602056240947% for the Past 3 years.
  • The company has shown a poor revenue growth of -2.19142259522154% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 940.19 851.95 567.99 842.2 768.03
Total Expenditure 750.91 674.54 465.39 674.33 651.11
Operating Profit 189.28 177.42 102.6 167.87 116.92
Other Income 3.43 1.81 2.78 5.61 30.49
Interest 19.79 17.52 14.56 17.21 13.49
Depreciation 36.41 35.85 34.75 37.66 37.97
Exceptional Items 0 0 0 0 30.75
Profit Before Tax 136.51 125.86 56.07 118.6 126.69
Tax 39.3 32.08 14.68 28.49 32.64
Profit After Tax 97.22 93.78 41.39 90.11 94.05
Adjusted EPS (Rs) 4.01 3.87 1.71 3.72 3.88

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 3134.98 3238.44 3931.2 3755.09 3030.16
Total Expenditure 2273.61 2594.4 3095.91 2953.73 2465.36
Operating Profit 861.37 644.04 835.29 801.36 564.8
Other Income 13.72 18.12 12.88 5.78 40.68
Interest 23.77 16.35 38.67 72 62.78
Depreciation 118.45 126.16 145.56 143.85 146.23
Exceptional Items 0 0 0 0 30.75
Profit Before Tax 732.87 519.65 663.94 591.29 427.22
Tax 180.09 133.13 165.16 155.37 107.89
Net Profit 552.78 386.52 498.79 435.92 319.34
Adjusted EPS (Rs.) 22.32 15.58 20.61 17.99 13.17

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 24.77 24.8 24.2 24.24 24.25
Total Reserves 2137.85 2505.86 2675.26 3086.71 3378.76
Borrowings 333.81 233.7 148.64 50.01 0
Other N/C liabilities 58.07 66.66 61.4 76.12 148.43
Current liabilities 1128.33 1541.6 1593.77 1768.55 1600.44
Total Liabilities 3682.83 4372.62 4503.27 5005.63 5151.87
Assets
Net Block 985 1170.83 1329.8 1323.67 1405
Capital WIP 146.58 194.15 63.46 52.53 120.25
Intangible WIP 17.43 16.38 0 0.41 0.54
Investments 591.53 596.53 676.53 941.4 1281.53
Loans & Advances 64.42 64.08 115.52 53.7 57.64
Other N/C Assets 0 0 0 0 0
Current Assets 1877.87 2330.65 2317.97 2633.92 2286.91
Total Assets 3682.83 4372.62 4503.27 5005.63 5151.87
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 732.87 519.65 663.94 591.29 427.22
Adjustment 153.72 137.11 178.19 229.36 229.29
Changes in Assets & Liabilities -325.99 -233.77 -1.31 -346.65 257.02
Tax Paid -185.94 -142.7 -177.14 -157.07 -90.83
Operating Cash Flow 374.66 280.29 663.68 316.93 822.71
Investing Cash Flow -232.74 -317.51 -96.71 -301.74 -553.62
Financing Cash Flow -296.21 151.43 -519.47 26.14 -339.83
Net Cash Flow -154.29 114.21 47.5 41.33 -70.74

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 38.87 38.87 38.85 38.84 38.82
chigurupati uma devi 3.81 3.81 3.81 3.81 3.81
chigurupati priyanka 0.75 0.75 0.75 0.75 0.75
krishna prasad chigurupat... 31.69 31.69 31.67 31.66 31.65
nikhila reddy yedaguri 0.01 0.01 0.01 0.01 0.01
pragnya chigurupati 0.76 0.76 0.76 0.76 0.76
santhi sree ramanavarapu 0.35 0.35 0.35 0.35 0.35
suseela devi chigurupati 0.03 0.03 0.03 0.03 0.03
tyche investments private... 1.47 1.47 1.47 1.46 1.46
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 61.13 61.13 61.15 61.16 61.18
aditya birla sun life tru... 1.09 1.05 2.25 2.47 2.53
axis mutual fund trustee ... - - - - 2.60
basava sankara rao kolli 1.20 - - 1.20 1.20
edelweiss trusteeship co ... - - 1.25 1.29 1.24
investor education and pr... - - - - 0.14
kotak mahindra life insur... - - 1.36 - 1.65
life insurance corporatio... 3.49 4.26 4.26 5.27 5.33
sbi life insurance co. lt... - - 2.34 2.81 3.02
tata mid cap growth fund - - - 1.28 1.35
axis mutual fund trustee ... - - 2.46 2.74 -
investor education and pr... 0.13 0.13 0.13 0.14 -
kotak mahindra life insur... - - - 1.57 -
schroder international se... 1.46 1.46 1.46 1.46 -
ab sicav i - internationa... 1.08 1.23 1.69 - -
basava sankararao kolli - 1.20 1.20 - -
tata mutual fund - tata h... - - 1.16 - -
axis mutual fund trustee ... 2.62 2.79 - - -
fidelity funds - india fo... 2.65 1.83 - - -
akash bhanshali 1.10 - - - -
fidelity funds - asian sm... 1.34 - - - -
government pension fund g... 1.15 - - - -
mahima stocks private lim... 1.13 - - - -
quant mutual fund - quant... 2.20 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit INDIA RATINGS & RESEARCH
Credit FITCH
TYPE AGENCY Link
TYPE AGENCY Link
Research Geojit
Research HDFC Securities
Research HDFC Securities
Research BP Wealth
Research BP Wealth
Research HDFC Securities
Research Geojit BNP Paribas
Research Motilal Oswal

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY21
Concall Q4FY20
Concall Q3FY25
Concall Q3FY24
Concall Q3FY21
Concall Q3FY20
Concall Q2FY24
Concall Q2FY21
Concall Q2FY20
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q3FY20
Presentation Q2FY22
Presentation Q2FY21
Presentation Q2FY20
Presentation Q1FY22
Presentation Q1FY21

Company News

Granules India Stock Price Analysis and Quick Research Report. Is Granules India an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Granules India and its performance over the period of time. Granules India stock price today is Rs 490.45.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Granules India cash from the operating activity was Rs 822.706 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Granules India has a Debt to Equity ratio of 0.2385 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Granules India , the EPS growth was -26.7953 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Granules India has OPM of 18.6393933263656 % which is a good sign for profitability.
     
  • ROE: Granules India have a poor ROE of 9.8461 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Granules India is Rs 490.45. One can use valuation calculators of ticker to know if Granules India share price is undervalued or overvalued.
Last Updated on:
Brief about Granules India
X